These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20117931)

  • 1. Selection of inhibitory peptides for Aurora-A kinase from a phage-displayed library of helix-loop-helix peptides.
    Fujiwara D; Ye Z; Gouda M; Yokota K; Tsumuraya T; Fujii I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1776-8. PubMed ID: 20117931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a carbohydrate-binding domain with a helix-loop-helix structure.
    Matsubara T; Iida M; Tsumuraya T; Fujii I; Sato T
    Biochemistry; 2008 Jul; 47(26):6745-51. PubMed ID: 18540680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Modification of Phage-Displayed Helix-Loop-Helix Peptides to Construct Kinase-Focused Libraries.
    Fujiwara D; Mihara K; Takayama R; Nakamura Y; Ueda M; Tsumuraya T; Fujii I
    Chembiochem; 2021 Dec; 22(24):3406-3409. PubMed ID: 34605137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage selection of peptide "microantibodies".
    Fujiwara D; Fujii I
    Curr Protoc Chem Biol; 2013; 5(3):171-94. PubMed ID: 24391082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of peptides mimicking the ligands of proteins phosphorylated by protein kinase CK2.
    Cardellini E; Felici F; Gianfranceschi GL
    Peptides; 2004 Feb; 25(2):191-7. PubMed ID: 15063000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.
    Zhang L; Yan Y; Liu Z; Abliz Z; Liu G
    J Med Chem; 2009 Jul; 52(14):4419-28. PubMed ID: 19530700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitors.
    Blanchard S; William AD; Lee AC; Poulsen A; Teo EL; Deng W; Tu N; Tan E; Goh KL; Ong WC; Ng CP; Goh KC; Bonday Z; Sun ET
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2443-7. PubMed ID: 20338758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library.
    Skelton NJ; Russell S; de Sauvage F; Cochran AG
    J Mol Biol; 2002 Mar; 316(5):1111-25. PubMed ID: 11884148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneously synthesized peptides on continuous cellulose membranes as substrates for protein kinases.
    Toomik R; Edlund M; Ek P; Obrink B; Engström L
    Pept Res; 1996; 9(1):6-11. PubMed ID: 8727478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and conformational properties of protein fragments based on the Id family of DNA-binding and cell-differentiation inhibitors.
    Kiewitz SD; Cabrele C
    Biopolymers; 2005; 80(6):762-74. PubMed ID: 15880794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of selective aminothiazole aurora kinase inhibitors.
    Andersen CB; Wan Y; Chang JW; Riggs B; Lee C; Liu Y; Sessa F; Villa F; Kwiatkowski N; Suzuki M; Nallan L; Heald R; Musacchio A; Gray NS
    ACS Chem Biol; 2008 Mar; 3(3):180-92. PubMed ID: 18307303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, SAR studies, and X-ray co-crystallographic analysis of a novel furanopyrimidine aurora kinase A inhibitor.
    Coumar MS; Tsai MT; Chu CY; Uang BJ; Lin WH; Chang CY; Chang TY; Leou JS; Teng CH; Wu JS; Fang MY; Chen CH; Hsu JT; Wu SY; Chao YS; Hsieh HP
    ChemMedChem; 2010 Feb; 5(2):255-67. PubMed ID: 20039358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of glutamic acid in the -X chelating position of the helix-loop-helix calcium binding motif.
    Procyshyn RM; Reid RE
    Arch Biochem Biophys; 1994 Jun; 311(2):425-9. PubMed ID: 7911293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and biological evaluation of a novel aurora A kinase inhibitor.
    Sardon T; Cottin T; Xu J; Giannis A; Vernos I
    Chembiochem; 2009 Feb; 10(3):464-78. PubMed ID: 19199284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with aurora kinase inhibitors: a review.
    Boss DS; Beijnen JH; Schellens JH
    Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors.
    Meng Z; Kulkarni BA; Kerekes AD; Mandal AK; Esposite SJ; Belanger DB; Reddy PA; Basso AD; Tevar S; Gray K; Jones J; Smith EB; Doll RJ; Siddiqui MA
    Bioorg Med Chem Lett; 2011 Jan; 21(1):592-8. PubMed ID: 21075632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of aurora kinase inhibitors as anticancer agents.
    Pollard JR; Mortimore M
    J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
    Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
    Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and conformation of an analog of the helix-loop-helix domain of the Id1 protein containing the O-acyl iso-prolyl-seryl switch motif.
    Beisswenger M; Yoshiya T; Kiso Y; Cabrele C
    J Pept Sci; 2010 Jun; 16(6):303-8. PubMed ID: 20474042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of structure in antibody cross-reactivity between peptides and folded proteins.
    Craig L; Sanschagrin PC; Rozek A; Lackie S; Kuhn LA; Scott JK
    J Mol Biol; 1998 Aug; 281(1):183-201. PubMed ID: 9680484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.